Erectile Dysfunction / Premature Ejaculation News
Latest Health News and Medical News posted throughout the day, every day.
Updated: 27 weeks 2 days ago
Palatin Technologies, Inc. Announces Dosing Of Subcutaneous Bremelanotide Trial In Men
Palatin Technologies, Inc. (NYSE Amex: PTN) announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old...
Categories: Men's Health News
Discovery That Viagra Enhances Fetal Growth In Female Sheep May Have Human Implications
A joke among two Texas AgriLife Research scientists later turned into a fully-funded study. Viagra can aid fetal development in female sheep. Female sheep (ewes) are an agriculturally important species, which can serve as an excellent animal model for studying the physiology of human pregnancy, the researchers said...
Categories: Men's Health News
Significant Risks Posed By Counterfeit Internet Drugs
Men who buy fake internet drugs for erection problems can face significant risks from potentially hazardous contents and bypassing healthcare systems could leave associated problems like diabetes and high blood pressure undiagnosed. That's the warning just published online by IJCP the International Journal of Clinical Practice...
Categories: Men's Health News
NERI Research Findings Show That Erectile Dysfunction May Be Early Warning Of Future Cardiovascular Disease
In the first study of its kind, New England Research Institutes, Inc...
Categories: Men's Health News
NexMed Updates On Canadian Aproval Process For Vitaros
NexMed, Inc. (Nasdaq: NEXM), a specialty CRO and a developer of products based on the NexACT® technology, announced today that it received a Notice of Non-Compliance ("Notice") as part of the review process from Health Canada for its New Drug Submission ("NDS") for the Vitaros erectile dysfunction treatment filed in February 2008...
Categories: Men's Health News
VIVUS Announces Additional Results Of Phase 3 Avanafil Study In Erectile Dysfunction Showing Efficacy In 15 Minutes
VIVUS, Inc. (Nasdaq: VVUS) announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED)...
Categories: Men's Health News
Sexual Function Does Not Continuously Decline After Radiation Therapy Treatments For Prostate Cancer
Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the January 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American So...
Categories: Men's Health News
Women's Bodies And Minds Agree Less Than Men's On What's Sexy
Review study confirms gender difference in responses to sexual stimuli...
Categories: Men's Health News
Restless Leg Syndrome Linked With Erectile Dysfunction In Older Men
A study in the Jan. 1 issue of the journal Sleep shows that erectile dysfunction was more common in older men with restless leg syndrome (RLS) than in those without RLS, and the magnitude of this association increased with a higher frequency of RLS symptoms...
Categories: Men's Health News
Resolve To Improve Your Urologic Health In The New Year
This new year, make a resolution to improve your health and talk to your doctor about urologic conditions. Although urologic problems may seem embarrassing to talk about, these conditions are more common than you think and a delay in seeking medical attention could cause you unnecessary stress, prolong the problem and even increase your risk for a more serious condition...
Categories: Men's Health News
Modernizing The Treatment Of Sexual Dysfunction In Men
Modern, couple-oriented treatment for male sexual dysfunction takes the psychosocial aspects of sex into account, as well as focussing on the purely physical aspects of the problem. The importance of this biopsychosocial approach, whether one looks at disorders of desire, arousal or orgasm, is supported by intercultural comparisons, among other data...
Categories: Men's Health News
Modernizing The Treatment Of Sexual Dysfunction In Men
Modern, couple-oriented treatment for male sexual dysfunction takes the psychosocial aspects of sex into account, as well as focussing on the purely physical aspects of the problem. The importance of this biopsychosocial approach, whether one looks at disorders of desire, arousal or orgasm, is supported by intercultural comparisons, among other data...
Categories: Men's Health News
Penile Length Shortening After Radical Prostatectomy: Men's Responses
UroToday.com - Erectile dysfunction is the most commonly recognized side effect of radical prostatectomy (RP) for prostate cancer (CaP). However, post-surgery penile length shortening (PLS) is known to occur in up to three-fourths of men. The impact of PLS has not previously been assessed...
Categories: Men's Health News
Penile Length Shortening After Radical Prostatectomy: Men's Responses
UroToday.com - Erectile dysfunction is the most commonly recognized side effect of radical prostatectomy (RP) for prostate cancer (CaP). However, post-surgery penile length shortening (PLS) is known to occur in up to three-fourths of men. The impact of PLS has not previously been assessed...
Categories: Men's Health News
Pivotal Study For PSD502--The First Potential Treatment For Premature Ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE)...
Categories: Men's Health News
Pivotal Study For PSD502--The First Potential Treatment For Premature Ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE)...
Categories: Men's Health News
Zydena Is Efficacious In Once Daily Dosing For Erectile Dysfunction/Positive BPH Results
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED)...
Categories: Men's Health News
Zydena Is Efficacious In Once Daily Dosing For Erectile Dysfunction/Positive BPH Results
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED)...
Categories: Men's Health News
Risk Of Male Sexual Dysfunction Increases Following Workplace BPA Exposure
High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in the journal Human Reproduction, published by Oxford Journals...
Categories: Men's Health News
Risk Of Male Sexual Dysfunction Increases Following Workplace BPA Exposure
High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in the journal Human Reproduction, published by Oxford Journals...
Categories: Men's Health News
